Page last updated: 2024-11-02

phenylbutazone and Adenocarcinoma, Basal Cell

phenylbutazone has been researched along with Adenocarcinoma, Basal Cell in 2 studies

Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hafeman, DG1
Lucas, ZJ1

Reviews

1 review available for phenylbutazone and Adenocarcinoma, Basal Cell

ArticleYear
More about isonicotinic acid hydrazide toxicity.
    Food and cosmetics toxicology, 1970, Volume: 8, Issue:5

    Topics: Adenocarcinoma; Adenofibroma; Adenoma; Animals; Carcinoma; Chemical and Drug Induced Liver Injury; C

1970

Other Studies

1 other study available for phenylbutazone and Adenocarcinoma, Basal Cell

ArticleYear
Polymorphonuclear leukocyte-mediated, antibody-dependent, cellular cytotoxicity against tumor cells: dependence on oxygen and the respiratory burst.
    Journal of immunology (Baltimore, Md. : 1950), 1979, Volume: 123, Issue:1

    Topics: Adenocarcinoma; Amobarbital; Animals; Antibody-Dependent Cell Cytotoxicity; Glucose; Humans; Hypoxia

1979